Roivant Sciences Q2 Adj. EPS $(0.28) Beats $(0.33) Estimate, Sales $1.571M Miss $6.947M Estimate

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.33) by 16.17 percent. This is a 12 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $1.571 million which missed the analyst consensus estimate of $6.947 million by 77.38 percent. This is a 64.89 percent decrease over sales of $4.475 million the same period last year.